Promoting Gastrointestinal Health and Reducing Subclinical Inflammation in Obese Individuals
1 other identifier
interventional
52
1 country
1
Brief Summary
This study evaluates the impact of increased intake of fruits and vegetables and whole grains on markers of inflammation and gut microbial composition. The treatment groups are 3 servings of whole grain per day; 5 servings of fruits and vegetables per day; and a control (3 servings of refined grains per day provided).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable obesity
Started Oct 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2015
CompletedFirst Submitted
Initial submission to the registry
November 4, 2015
CompletedFirst Posted
Study publicly available on registry
November 11, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2017
CompletedResults Posted
Study results publicly available
May 10, 2019
CompletedJune 5, 2019
May 1, 2019
1.7 years
November 4, 2015
November 27, 2017
May 22, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change in Interleukin-6 (Value at Week 8 Minus Value at Week 0)
Plasma samples collected from participants at the beginning (week 0) and end of the study (week 8) will be analyzed for interleukin-6 concentrations using an enzyme linked immunosorbent assay. Changes in the concentrations of these inflammatory markers will be determined from week 0 to week 8.
8 weeks
Change in Tumor Necrosis Factor-α (Value at Week 8 Minus Value at Week 0)
Plasma samples collected from participants at the beginning (week 0) and end of the study (week 8) will be analyzed for tumor necrosis factor-α concentrations using an enzyme linked immunosorbent assay. Changes in the concentrations of these inflammatory markers will be determined from week 0 to week 8.
8 weeks
Change in High Sensitivity C-reactive Protein (Value at Week 8 Minus Value at Week 0)
Plasma samples collected from participants at the beginning (week 0) and end of the study (week 8) will be analyzed for high sensitivity C-reactive protein concentrations using an enzyme linked immunosorbent assay. Changes in the concentrations of these inflammatory markers will be determined from week 0 to week 8.
8 weeks
Change in Lipopolysaccharide Binding Protein (Value at Week 8 Minus Value at Week 0)
Plasma samples collected from participants at the beginning (week 0) and end of the study (week 8) will be analyzed for lipopolysaccharide binding protein concentrations using an enzyme linked immunosorbent assay. Changes in the concentrations of these inflammatory markers will be determined from week 0 to week 8.
8 weeks
Secondary Outcomes (3)
Change in Gut Microbiota Shannon's Alpha Diversity (Value at Week 8 Minus Value at Week 0)
8 weeks
Change in Fecal Short Chain Fatty Acids (Value at Week 8 Minus Value at Week 0)
8 weeks
Change in Branched Chain Fatty Acids (Value at Week 8 Minus Value at Week 0)
8 weeks
Other Outcomes (1)
Change in Body Mass Index (Value at Week 8 Minus Value at Week 0)
8 weeks
Study Arms (3)
Control
EXPERIMENTAL3 servings of refined grains per day.
Fruits and Vegetables
EXPERIMENTAL5 servings of fruits and vegetable per day.
Whole Grain
EXPERIMENTAL3 servings of whole grains per day.
Interventions
Eligibility Criteria
You may qualify if:
- Obese or overweight men or women (body mass index, BMI, ≥25 kg/m2)
- Free of known gastrointestinal disease
- No supplements use (excluding multivitamin)
- Participate in less than 1 h of exercise per week
- Have not taken antibiotics in the last six months
You may not qualify if:
- Men and women with fruits and vegetable intake exceeding 2 servings/day
- Men and women with whole grain intakes exceeding 1 serving/day
- Pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Food Innovation Center
Lincoln, Nebraska, 68588, United States
Related Publications (1)
Kopf JC, Suhr MJ, Clarke J, Eyun SI, Riethoven JM, Ramer-Tait AE, Rose DJ. Role of whole grains versus fruits and vegetables in reducing subclinical inflammation and promoting gastrointestinal health in individuals affected by overweight and obesity: a randomized controlled trial. Nutr J. 2018 Jul 30;17(1):72. doi: 10.1186/s12937-018-0381-7.
PMID: 30060746DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Devin Rose
- Organization
- University of Nebraska Lincoln
Study Officials
- PRINCIPAL INVESTIGATOR
Devin J Rose, PhD
University of Nebraska
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
November 4, 2015
First Posted
November 11, 2015
Study Start
October 1, 2015
Primary Completion
June 1, 2017
Study Completion
July 1, 2017
Last Updated
June 5, 2019
Results First Posted
May 10, 2019
Record last verified: 2019-05